Navigation Links
BioMS Medical Announces 2007 Year End Results
Date:3/18/2008

Toronto Stock Exchange Symbol: MS

EDMONTON, March 18 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis ("MS"), today announced financial and operational results for the year ended December 31, 2007.

"We continue to focus on the worldwide development of MBP8298, our proprietary synthetic peptide drug for the treatment of multiple sclerosis, which is being evaluated in several late-stage trials in the U.S., Canada and across Europe," said Kevin Giese, President and CEO of BioMS Medical. "The magnitude of the partnership we formed with Lilly at the end of 2007 for the global rights to MBP8298 underscores the enormous potential of our drug and is a validation of all the years of hard work performed by our team."

Currently, BioMS is conducting three clinical trials and one open-label follow-on trial for MBP8298:

- MAESTRO-01: A pivotal phase II/III trial in Canada and Western Europe

evaluating MBP8298 for the treatment of secondary progressive MS

("SPMS"). On January 22, 2007, BioMS announced that the trial had

completed full recruitment of 611 patients at 47 trial sites in

10 countries. Patients are administered either MBP8298 or placebo

every six months for a period of two years. To date, there have been

eight positive safety reviews from the Data Safety Monitoring Board

("DSMB"). An interim analysis on the first 200 patients is expected

in mid-2008.

- MAESTRO-02: An open-label follow-on study to the MAESTRO-01 pivotal

trial. Eligible patients who have successfully completed the blinded,

placebo controlled MAESTRO-01 trial may choose to receive MBP8298 on

an un-blinded basis.

- MAESTRO-03: A U.S. pivotal phase III trial evaluating MBP8298 for the

treatment of SPMS. Enrollment for the randomized, double-blind s
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. BioMS Medical to present at BIO CEO & Investor Conference
2. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
3. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
4. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
5. BioMS Medical announces third quarter 2007 results
6. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
7. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. BioMS Medical to present at BioContact 2007
9. BioMS Medical announces its intention to renew a normal course issuer bid
10. First Patient Enrolled in SONIC I Registry of OmniSonics Medical Technologies OmniWave(TM) Endovascular System
11. GHI Medical Deploys New Test to Help Determine Hair Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014 OHAUS Corporation, a ... mechanical balances and scales, proudly announces its Explorer ... Laboratory Equipment magazine’s 2014 “Readers' Choice” Award for ... year the Explorer was voted the best laboratory ... Choice Awards celebrates “excellence in product design and ...
(Date:7/22/2014)... Massachusetts og SHENZHEN ... Tech Solutions Co., LTD, (BGI Tech), et datterselskab ... lancering af en ny human whole exome-sekvenseringstjeneste baseret ... Complete Genomics, højt anset i branchen for at ... højfølsom registrering af alle typer varianter, blev købt ...
(Date:7/22/2014)... en SHENZHEN, China , ... LTD, (BGI Tech), een dochtermaatschappij van BGI, ,s wereld ... wereldwijde introductie aan van een nieuwe service ten behoeve ... meest geavanceerde platform van Complete Genomics. ... binnen de sector in hoog aanzien staat vanwege de ...
(Date:7/22/2014)... Hussey Copper , a leader in ... copper announces Pullman Regional Hospital,s conversion of more than ... touch surface, at a nominal cost.  This reasonably priced ... other bacteria within 2 hours of exposure 1 and ... infectious diseases in its facilities. Pullman Regional ...
Breaking Biology Technology:OHAUS Explorer Voted “Best Balance” in Laboratory Equipment’s 2014 Readers’ Choice Awards 2BGI Tech lancerer Human Whole Exome-sekvenseringstjeneste på Complete Genomics avancerede platform 2BGI Tech introduceert service op gebied van hele menselijke exoomsequencing op geavanceerd Complete Genomics-platform 2Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 2Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 3
... has been appointed to the board of directors of ... former president of the American Society of Therapeutic Radiation ... radiation oncology. , ,Perez is professor emeritus in ... Radiology, Siteman Cancer Center, Washington University Medical Center. , ...
... the universal presentation tool that isn't universally loved. But Microsoft's ... and shouldn't be if its use in distance learning is ... "Kit" Horton, a partner in the Denver-based William Horton ... of sneer, smile and say, `That's nice,'" said Horton, who, ...
... Inc., a University of Wisconsin-Madison spin-off developing high-power diode ... $4.5 million from the Army Research Laboratory in Adelphi, ... of a high-power, high-brightness multimode diode laser source with ... are a type of compact and monolithic solid-state laser ...
Cached Biology Technology:Bringing distance learning alive 2Alfalight awarded $4.5 million Army Research contract 2
(Date:7/22/2014)... July 22, 2014 BGI Tech Solutions Co., ... world,s largest genomics organization, announced today the global ... service based on Complete Genomics, industry-leading platform. This ... SNP validation, and is available at reduced prices ... highly regarded in the industry for providing proprietary ...
(Date:7/22/2014)... child,s lunch box and you,re likely to find that the ... are the findings of a study conducted by researchers at ... University and in the Department of Public Health and Community ... are published online ahead of print in the Journal ... Led by senior author Jeanne Goldberg, Ph.D., R.D., a professor ...
(Date:7/21/2014)... July 21, 2014 (Toronto) As part of a ... and Mental Health (CAMH) have helped identify over 100 ... of developing schizophrenia, in what is the largest genomic ... findings, published online in Nature , point to ... could lead to new approaches to treating the disorder, ...
Breaking Biology News(10 mins):BGI Tech launches human whole exome sequencing service on complete genomics' advanced platform 2Room for improvement in elementary school children's lunches and snacks from home 2International team sheds new light on biology underlying schizophrenia 2International team sheds new light on biology underlying schizophrenia 3
... Nov. 12, 2013 One of the most comprehensive ... today, demonstrating an unprecedented level of genetic variation that ... ovarian cancer. The study highlights potential new pathways for ... multiple disease sites may be required for effective targeted ...
... as clear as glass, or why bakers use sugar, even ... in the American Chemical Society,s (ACS,) latest Bytesize Science ... . "Everything that happens in the kitchen is science," ... of it, you,re going to have more power over your ...
... protein, they tend to eat a small amount at ... at dinner. New research presented today at The ... eating high protein sausage and egg-based breakfasts curbed hunger ... and syrup) or skipping breakfast, in 18-55-year-old women., ...
Cached Biology News:Clinical ovarian cancers display extensive genetic heterogeneity, study suggests multiple treatment 2Clinical ovarian cancers display extensive genetic heterogeneity, study suggests multiple treatment 3
Request Info...
Purified Mouse anti-Hu LAT (pY226) Storage Temperature: Refrigerate(2 to 8C)...
Molecular Biology grade. Ideally suited for DNA and RNA separation and recovery. High gel strength. Gelling temp. 36C. Melting temp. 88C. EEO: 0.05-0.13 Resolution 0.2-40 kb; Rnase/Dnase: none detec...
...
Biology Products: